Miconazole at minimal fungitoxic concentrations inhibits ergosterol biosynthesis in sporidia of Ustilago maydis by interference with sterol C14 demethylation. The action is analogous to that of the fungicides tiarimol and fenariniol. The fungicide 1-dodecylimidazole at low concentrations (0.1 to 0.25 yg/ml) inhibits sterol C14 demethylation; however, at higher concentrations (1.0 ug/ml or greater) it also inhibits 2,3-oxidosqualene cyclization and subsequent tranamethylation. It is postulated that this diversity of effects of 1-dodecylimidazole results from binding of the inhibitor to sterol carrier protein(s).
Miconazole is a fungitoxic agent with a wide antifungal spectrum used medically to control mycotic infections (27) . Various observations with Candida albicans after exposure times ranging from 3 to 24 h indicated that miconazole affects membrane permeability and transport as well as cell morphology (8-10, 26, 28) .
In studies with imazalil, a miconazole analog, Van Tuyl observed that cross-resistance invariably occured between the fonner compound and fenarimol in mutants of Aspergillus nidulans (30, 31) . Fenarimol, like triarimol, is an inhibitor of ergosterol biosynthesis (3, 19) . These results suggested that the mode of action of miconazole was possibly analogous to that of the sterol C14 demethylation inhibitors triarimol (18, 21) , fenarimol, imazalil (16, 24) , triadimefon (2), triforine (23) , and Denmert (14) . Recent studies show, in fact, that miconazole is an inhibitor of ergosterol biosynthesis in Ustilago maydis (12) and C. albicans (29) .
N-dodecylimidazole, like miconazole, is a fungitoxic 1-alkylimidazole. This compound is reported to inhibit cholesterol biosynthesis in rat livers (K. H. Baggaley, R. M. Hindley, J. L. Tee, and G. S. Brooks, British Patent 1,364,312, January 1971). Atkin et al. concluded that it is a specific inhibitor of 2,3-oxidosqualene cyclase, the enzyme which converts 2,3-oxidosqualene to lanosterol (1) . It was of interest to compare the effects of these two inhibitors on the sterol biosynthetic pathway in U. mnaydis, an organism in which the action of triarimol has been thoroughly investigated (12, 18, 20, 21) . This report presents the results of these investigations.
MATERIALS AND METHODS Sporidia of U. maydis (DC) Cda. ATCC 14826 were cultured as previously described (5, 20) , in a defined nutrient medium at an initial concentration of 6.9 x 106 sporidia per ml (0.2 mg [dry Wvt] per ml). Inhibitors were added as methanolic solutions so that the methanol did not exceed 1% in the culture media. After centrifugation from culture media, sporidia were lyophilized, and crude lipids were extracted with chloroform-methanol (2:1, vol/vol) (11, 18, 20 number With little delay, but strongly suppressed multiplication thereafter. There was essentially no effect on dry weight increase during the first doubling, but it was markedly inhibited thereafter, although less so than was sporidial multiplication. A concentration of 5.0 ug/ml ANTIMICROB. AGENTS CHEMOTHER.
completely prevented both sporidial multiplication and dry weight increase, indicating possible involvement of a secondary toxicity mechanism which is nonoperative at lower concentrations. The effects of 0.025 and 0.1 ,ug of miconazole per ml resembled those produced by 0.25 ,ug/ml; however, there was nearly total recovery from the toxic effects of the two lower concentrations after 12 to 24 h.
Concentrations of 0.25 and 1.0 ,ug of dodecylimidazole per ml produced initial effects on sporidial multiplication and dry weight increase more severe than those of 0.25 ug of miconazole per ml, but there was a greater tendency for recovery after the first sporidial division than there was with miconazole (Table 1) . Concentrations of 2.5 and 5.0 ,ug/ml completely prevented increase in cell number and dry weight.
Analyses of sterols showed patterns of effects by miconazole essentially identical to those produced by triarimol ( Table 2 ). Ergosterol biosynthesis was inhibited by both compounds, and two other sterols accumulated concurrently. These sterols, which had retention times relative to cholesterol of 1.89 and 1.52, were previously identified as 24-methylenedihydrolanosterol and obtusifoliol in triarimol-treated cells of U. maydis (18) . A mass spectrum recorded for the former sterol was consistent with that reported by Ragsdale (18) . Exposure to either inhibitor for 6 h resulted in a small accumulation of 14-amethyl-_A824(11 -ergostadienol, a sterol previously reported by Ragsdale (18) to accumulate in triarimol-treated sporidia.
The effect of 0.1 and 0.25 ug of dodecylimidazole per ml on sterol biosynthesis was nearly identical to that produced by 2 ,ug of triarimol per ml or 0.25 ,ug of miconazole per ml. However, the effects of 1.0 ,tg of dodecylimidazole per ml differed markedly in some respects from those of the above concentrations of triarimol and miconazole (Table 3) . Although there were sim- ilarities with respect to inhibition of ergosterol biosynthesis and accumulation of 24-methylenedihydrolanosterol, appreciable quantities of another sterol and a nonsterol component not normally detectable in control or miconazole or triarimol-treated sporidia were present.
The sterol was identified as lanosterol on the basis of the same gas-liquid chromatography retention time and TLC mobility as a lanosterol standard (Sigma The present study demonstrates that triarimol and miconazole, at their lowest effective fungitoxic levels, inhibit ergosterol biosynthesis by analogous mechanisms in U. maydis, i.e., by inhibition of sterol C14 demethylation. This inhibition appears to be a primary biochemical lesion leading to fungitoxicity of both compounds. Membrane damage caused by low concentrations of miconazole in C. albicans (26, 28) undoubtedly is due to an ergosterol deficiency resulting from inhibition of sterol C14 demethylation. Recent studies of the action of miconazole in C. albicans by Van den Bossche (29) also indicate the involvement of such a mechanism leading to membrane damage. Although C14 methyl sterols accumulate, it has been shown that these do not function effectively as membrane components (32) .
With respect to the mode of action of dodecylimidazole in U. maydis, our data indicate that the compound is not a specific inhibitor of 2,3-oxidosqualene cyclase in the sterol biosynthetic pathway, as was reported to be the case in rat livers (1) Sterol carrier protein(s) are involved in all steps of sterol biosynthesis from squalene to cholesterol (7, 22) . In view of the diversity of reaction types affected by low concentrations of dodecylimidazole, the action of the compound is best explained by assuming that it binds to the carrier protein(s) and thus interferes with the interaction of several types of enzymes with the sterol carrier protein-sterol (2,3-oxidosqualene) complex. The binding of AY-9944 to sterol carrier protein has been described as the mechanism of inhibiting sterol biosynthesis (6) , and such a mechanism of interference has also been suggested for triarimol (18) and triforine (23) . This type of interference may be the common basis of action for the fungitoxic compounds imazalil (16, 24) , triarimol (18) , fenarimol (3, 19) , triforine (23) , triadimnefon (2), and Denmert (14, 15 
